Clostridioides difficile Infection
C. diff High-yield Verified · Sep 2026Clostridioides difficile infection is colitis caused by toxins from C. difficile, a spore-forming, Gram-positive anaerobic bacillus that is the leading cause of antibiotic-associated diarrhea.
C. diff spores survive for months on surfaces and are not killed by alcohol hand rub or ordinary hospital disinfectants. A course of antibiotics disrupts the gut microbiome, the spores take hold, and toxins damage the colon lining — from mild watery diarrhea to pseudomembranous colitis, toxic megacolon, perforation and septic shock. Nursing controls the spread: contact precautions, soap and water, dedicated equipment and sporicidal cleaning.
What’s going wrong in the body
The normal physiology, where it fails, and why the body’s compensation backfires.
01 Antibiotics clear the way; toxins injure the colon
The organism. CDC: "C. diff is a spore-forming, Gram-positive anaerobic bacillus that produces two exotoxins: toxin A and toxin B." It causes 15 to 25% of antibiotic-associated diarrhea (CDC).
Dysbiosis. CDC: "Antibiotics kill harmful bacteria that cause infections, but they can also kill helpful bacteria in your gut." With fewer and less varied helpful bacteria, the body’s natural defenses weaken, "allowing C. diff germs to grow and potentially cause an infection." "The effects of antibiotics on the gut microbiome can last for several months."
Toxin injury. StatPearls: diarrhea and pseudomembranous colitis "result from clostridial glycosylation exotoxins—toxin A (TcdA), an enterotoxin, and toxin B (TcdB), which is cytotoxic." Inside the cell, both toxins inactivate Rho-protein pathways, "resulting in damage to colonocytes, disruption of intercellular tight junctions, and colitis."
Colonized is not infected. CDC: "Colonization with C. diff is more common than infection." Colonized people often have no symptoms but "do test positive for the C. diff organism or its toxin." StatPearls: C. difficile can colonize "up to 3% to 5% of healthy individuals," and asymptomatic people with positive toxin tests do not need treatment.
02 Spores: why alcohol and ordinary disinfectants fail
Built to last. CDC: outside the body the germs become spores with "a protective coating allowing them to live for months or years on surfaces and in the soil." "Spores become active again after being swallowed and reaching the intestines."
Hands and surfaces carry them. "C. diff sheds in feces. Any surface, device or material that becomes contaminated with feces could serve as a reservoir for the C. diff spores." "C. diff spores can transfer to patients by the hands of healthcare personnel who have touched a contaminated surface or item" — electronic rectal thermometers, stethoscopes and blood pressure cuffs among them.
Resistant to the usual products. The SHEA/IDSA/APIC compendium: spores "are resistant to the bactericidal effects of alcohol and commonly used hospital disinfectants (eg, phenolics and quaternary ammonium compounds)." CDC: "Gloves are important because hand sanitizer doesn’t kill C. diff." Rooms need an EPA-approved spore-killing disinfectant (List K); a 1:10 dilution of household bleach is one option.
Evidence nuance. The compendium notes that although alcohol rub "is ineffective at removing or disinfecting C. difficile spores in controlled laboratory experiments, no clinical study has demonstrated an increase in CDI with the use of these products." It lists soap and water after care as the preferred method (an additional approach), and CDC and StatPearls teach soap and water plus gloves.
03 Severe and fulminant disease, toxic megacolon
The spectrum. StatPearls: from "asymptomatic carriers to symptomatic patients experiencing mild diarrhea to severe manifestations such as fever, abdominal pain, pseudomembranous colitis, toxic megacolon, and septic shock." Common symptoms include "watery diarrhea with mucus or occult blood, anorexia, nausea, vomiting, low-grade fever, and lower abdominal pain."
Severe markers (StatPearls). "Severe C difficile infection is characterized by a white blood cell count exceeding 15,000 cells/μL, serum albumin below 3 g/dL, and serum creatinine elevated to more than 1.5 times the premorbid level." A fulminant episode has hypotension, shock, ileus or megacolon.
Toxic megacolon (StatPearls, any cause). Diagnosis requires colon dilation above 6 cm on imaging, at least 3 of fever over 38 °C, heart rate above 120/min, neutrophilic leukocytosis above 10,500/µL or anemia, and at least 1 of altered sensorium, hypotension, hypovolemia or electrolyte abnormalities. "Features suggestive of peritonitis, including fever and severe abdominal pain, may indicate bowel perforation." Opioids and anticholinergics "should be discontinued," and corticosteroids can mask its severity.
Causes & risk factors
Modifiable factors are teaching targets — the patient can act on them.
Signs & symptoms
Each finding tied to the mechanism that produces it — and the triage it calls for.
Diagnostics
Complications
Medications for this condition
Why each class is prescribed here — every card links to its full pharmacology page.
Oral vancomycin is standard of care (CDC: an "appropriate course (about 10 days) of treatment, including oral vancomycin or fidaxomicin"). SHEA/IDSA 2021 (adults) suggests fidaxomicin over a standard vancomycin course for a first episode because of lower recurrence — "Vancomycin remains an acceptable alternative." For fulminant CDI, vancomycin by mouth or nasogastric tube. Label: "Parenteral administration of vancomycin is not effective for the above infections; therefore, vancomycin must be given orally for these infections." Nephrotoxicity has occurred with oral therapy, especially in older adults — "Monitor renal function." Take the whole course even after feeling better. Fidaxomicin (DIFICID, a macrolide with minimal systemic absorption, approved from 6 months of age) is the other first-line option; stop it for a severe hypersensitivity reaction.
No longer first-line. StatPearls: "Metronidazole is no longer recommended as first-line therapy for C difficile infections and should only be considered in cases where vancomycin or fidaxomicin are unavailable." IV metronidazole is an adjunct in fulminant disease and may be needed if ileus is present.
A cause, not a cure. CDC lists clindamycin among the antibiotics most linked to CDI. If CDI develops, antibiotics not aimed at C. diff are reassessed and stopped or switched when safe.
A risk factor. StatPearls lists proton pump inhibitors among CDI risk factors; review the need for them with the prescriber.
Avoid. StatPearls (toxic megacolon): "medications that reduce intestinal motility, including opioids, anticholinergics, and certain antidiarrheal agents, may worsen colonic dilation and should not be used without clinician guidance." No source gives antidiarrheals a treatment role in CDI.
Beyond medications
- Stop or switch other antibiotics when safe — CDC: "Reassess appropriateness of antibiotics in C. diff patients."
- Fluids and supportive care — severe cases need hospital admission for fluids and monitoring.
- Fecal microbiota transplantation — SHEA/IDSA 2021: only "for patients with multiple recurrences of CDI who have failed appropriate antibiotic treatments" with donor screening; FDA safety alerts documented transmission of pathogenic E. coli.
- Surgery — subtotal colectomy with rectal preservation may be needed for fulminant colitis.
- Antibiotic stewardship — StatPearls: 30% to 50% of prescribed antibiotics are unnecessary or incorrect. Probiotic prophylaxis has shown variable results (SHEA/IDSA/APIC compendium) and is not a recommendation.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
How a real nurse thinks
The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.
- 1 Recognize cues
New watery, unformed stools (5 in 18 hours) after broad-spectrum antibiotics (a cephalosporin and a fluoroquinolone), age over 65, a PPI, fever, tachycardia, WBC 17,200 and albumin 2.8 — and she is in a shared room.
- 2 Analyze cues
Suspected CDI. WBC above 15,000 and albumin below 3 g/dL meet StatPearls markers of severe disease. There is no hypotension, ileus or distension yet, so not fulminant — but an antidiarrheal could worsen colonic dilation.
- 3 Prioritize
Stop the spread and prevent deterioration: isolate now, get a proper specimen, hold the antidiarrheal, and alert the provider to the severe markers and the ongoing antibiotics.
- 4 Generate solutions
Move to a private room with contact precautions and dedicated equipment; send an unformed stool promptly; ask the provider to review the antibiotics, the PPI and the antidiarrheal order; anticipate oral vancomycin or fidaxomicin; monitor fluid status, abdomen and vital signs.
- 5 Take action
The nurse places her on contact precautions before the result returns, sends the specimen to the lab at once, washes hands with soap and water after care, holds the antidiarrheal, and reports the fever, WBC, albumin and antibiotic list to the provider, who starts oral vancomycin.
- 6 Evaluate
Over the next days the stools become less frequent and formed, fever resolves and the abdomen stays soft. Precautions continue until at least 48 hours after the diarrhea stops; no repeat test for cure is sent.
Scenario — you’re the nurse
Work each question before revealing the answer. Rationales explain the wrong options too.
A 74-year-old woman admitted with pneumonia has received an IV third-generation cephalosporin and an oral fluoroquinolone for 6 days. She also takes a proton pump inhibitor. She now has frequent loose stools. She is in a shared room.
Q1 Select all that apply Which actions should the nurse take now? Select all that apply. - A. Place the patient on contact precautions before the test result returns
- B. Wear a gown and gloves for every room entry
- C. Clean hands with alcohol-based rub only after leaving the room
- D. Give the as-needed antidiarrheal for comfort
- E. Send an unformed stool specimen to the lab promptly
- F. Use a dedicated stethoscope and thermometer
Reveal answer & rationale
Q2 Multiple choice Which drug does the nurse anticipate for this adult’s first episode of C. diff? - A. IV vancomycin
- B. Oral vancomycin or fidaxomicin
- C. Oral metronidazole as first-line therapy
- D. Loperamide
Reveal answer & rationale
Q3 Multiple choice Two days later the patient has severe abdominal pain, a distended abdomen, HR 128, BP 86/50 and fewer stools. What is the priority? - A. Document the improvement in stool frequency
- B. Notify the provider immediately — suspect fulminant colitis or toxic megacolon
- C. Send a stool sample for a test of cure
- D. Give an antidiarrheal to prevent further fluid loss
Reveal answer & rationale
Q4 Select all that apply Which statements about ending precautions and follow-up are correct? Select all that apply. - A. Continue contact precautions at least 48 hours after diarrhea resolves
- B. Repeat the stool test to prove cure before discharge
- C. Clean the room with an EPA-registered sporicidal disinfectant at discharge
- D. Tell future prescribers about the C. diff history before new antibiotics
- E. Stop vancomycin once the diarrhea stops
Reveal answer & rationale
Common questions
What causes clostridioides difficile infection?
Why can’t I use hand sanitizer for C. diff?
Should a patient without diarrhea be tested?
Is metronidazole still used for C. diff?
How long do contact precautions last?
Can C. diff come back?
Sources
- Clostridioides difficile Infection — StatPearls — StatPearls (NCBI Bookshelf)
- C. diff: Facts for Clinicians — CDC — Centers for Disease Control and Prevention
- About C. diff — CDC — Centers for Disease Control and Prevention
- Preventing C. diff — CDC — Centers for Disease Control and Prevention
- Clinical Testing and Diagnosis for C. diff Infection — CDC — Centers for Disease Control and Prevention
- Clinical Practice Guideline by IDSA and SHEA: 2021 Focused Update on Management of Clostridioides difficile Infection in Adults — Infectious Diseases Society of America
- Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update (SHEA/IDSA/APIC compendium) — Infection Control & Hospital Epidemiology (PMC, CC BY)
- Toxic Megacolon — StatPearls — StatPearls (NCBI Bookshelf)
- FIRVANQ (vancomycin hydrochloride) for oral solution — FDA label — U.S. FDA / NLM DailyMed
- DIFICID (fidaxomicin) — FDA label — U.S. FDA / NLM DailyMed
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.